New Delhi, Dec 27 || A team of US researchers has developed and validated an artificial intelligence (AI)-based non-invasive tool that can predict the risk of head and neck cancer spread.
The AI tool by researchers from the Mass General Brigham could predict the likelihood that a patient's oropharyngeal cancer -- a type of head and neck cancer that develops in the throat -- will spread. It could help doctors by signaling which patients should receive aggressive treatment.
"Our tool may help identify which patients should receive multiple interventions or would be ideal candidates for clinical trials of intensive strategies such as immunotherapy or additional chemotherapy," said senior author Benjamin Kann, the Artificial Intelligence in Medicine (AIM) Programme at Mass General Brigham.
"Our tool can also help identify which patients should undergo de-intensification of treatment, such as surgery alone," Kann added.
The research is published in the Journal of Clinical Oncology.